GlucoTrack (GCTK) news
Recent news
Glucotrack - Announces 1-for-15 reverse stock split effective August 31, 2026
AInvest Wire · 4d agoGlucotrack - enters amendment No. 1 to stock purchase agreement with White Lion Capital on Aug 7th - SEC filing
On August 7, 2026, Glucotrack, Inc. executed Amendment No. 1 to its Stock Purchase Agreement with White Lion Capital, as disclosed in a recent SEC filing. The amendment outlines adjustments to the original terms of the agreement, though specific details of the modifications have not been publicly…
AInvest Wire · Aug 10, 2026Glucotrack announces $5.5 million financing
AInvest Wire · Aug 5, 2026Glucotrack and Lōkahi Therapeutics complete strategic business combination, establishing Lōkahi-controlled public platform
Glucotrack, Inc. (Nasdaq: GCTK) has completed a strategic business combination with Lōkahi Therapeutics, forming a publicly listed entity designed to leverage capital efficiency and advanced healthcare asset development. The transaction positions Lōkahi Therapeutics as the operating and controlling…
AInvest Wire · Jul 16, 2026Glucotrack - Lokahi shareholders to own 90% of Glucotrack equity post-merger - SEC filing
AInvest Wire · Jul 15, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.